Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
12
Number of overlapping holdings
24.0%
% of FTXH's 51 holdings also in PPH
50.0%
% of PPH's 27 holdings also in FTXH
Overlap by Weight
Sector Drift (FTXH minus PPH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FTXH |
Weight in PPH |
Overlap | |
|---|---|---|---|---|
 |
JOHNSON & JOHNSON | 7.2% | 6.4% | 6.4% |
|
ABBVIE INC | 7.2% | 6.0% | 6.0% |
|
MERCK & CO. INC. | 7.2% | 5.1% | 5.1% |
|
BRISTOL-MYERS SQUIBB CO | 7.2% | 5.0% | 5.0% |
|
PFIZER INC | 7.4% | 4.6% | 4.6% |
Position Highlights (Non-Overlapping Exposures)
FTXH Overweight Relative to PPH
|
GILEAD SCIENCES INC | 3.9% |
|
AMGEN INC | 3.7% |
|
CARDINAL HEALTH INC | 3.6% |
|
BIOGEN IDEC INC | 3.5% |
|
REGENERON PHARMACEUTICALS | 3.5% |
|
UNITED THERAPEUTICS CORP | 3.4% |
|
PFIZER INC | 2.8% |
|
CHARLES RIVER LABORATORIES | 2.5% |
|
ORGANON & CO. | 2.3% |
|
BRISTOL-MYERS SQUIBB CO | 2.2% |
FTXH Underweight Relative to PPH
|
ELI LILLY & CO | -9.4% |
 |
NOVO-NORDISK A/S-SPONS ADR | -8.6% |
 |
NOVARTIS AG-ADR | -5.3% |
 |
SANOFI-AVENTIS-ADR | -5.1% |
 |
TAKEDA PHARMACEUTICAL CO. LTD. SPONS | -4.8% |
 |
ASTRAZENECA PLC-SPONS ADR | -4.7% |
|
GLAXOSMITHKLINE PLC-SPON ADR | -4.3% |
|
AMERISOURCEBERGEN CORP | -4.3% |
|
MCKESSON CORP | -3.7% |
 |
TEVA PHARMACEUTICAL-SP ADR | -3.4% |